drugset / Trial / NCT05354466

Perioperative Respiratory Adverse events_sugammadex

NCT05354466

Phase 4 Completed 174 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindOther

Summary

Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiving tonsillectomy

Timeline

Start
2022-06-27
Primary completion
2024-09-04
Completion
2024-09-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified
Subject Sugammadex Other / unclassified